Paul Matteis - Stifel Nicolaus Analyst Performance This page shows the methodology used to calculate Paul Matteis's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsVRTXVertex Pharmaceuticals8/5/2025$472.27$455.00Hold???%???%NBIXNeurocrine Biosciences7/31/2025$131.49$174.00Buy???%???%DYNDyne Therapeutics7/31/2025$9.90$36.00Buy???%???%RYTMRhythm Pharmaceuticals5/29/2025$62.66$94.00Buy???%???%VIGLVigil Neuroscience5/28/2025$7.88$8.00Hold???%???%ALNYAlnylam Pharmaceuticals3/31/2025$268.46$345.00Buy???%???%NMRANeumora Therapeutics3/7/2025$1.52$2.00Hold???%???%RYTMRhythm Pharmaceuticals3/5/2025$54.02$78.00Buy???%???%SIONSionna Therapeutics3/4/2025$14.41$32.00Buy???%???%CMPSCOMPASS Pathways2/27/2025$3.70$11.00Buy???%???%GHRSGH Research2/27/2025$10.82$32.00Buy???%???%DYNDyne Therapeutics3/11/2022$8.74$29.00Buy???%???%BIIBBiogen3/8/2022$205.78$223.00Hold???%???%BIIBBiogen2/3/2022$220.41$304.00???%???%VRTXVertex Pharmaceuticals1/27/2022$229.23$222.00Hold???%???%BIIBBiogen10/15/2021$280.88$344.00Buy???%???%PRVLPrevail Therapeutics12/16/2020$22.90$23.00Hold???%???%KRTXKaruna Therapeutics6/3/2020$95.70$135.00Buy???%???%ZGNXZogenix2/14/2020$32.18Buy???%???%NBIXNeurocrine Biosciences2/14/2020$104.30$127.00Buy???%???%SAGESage Therapeutics11/20/2019$151.48Buy???%???%BMRNBioMarin Pharmaceutical9/13/2019$72.65$108.00Buy???%???%ACADACADIA Pharmaceuticals9/9/2019$41.39$39.00Hold???%???%ALNYAlnylam Pharmaceuticals9/3/2019$79.82$116.00Buy???%???%ALXNAlexion Pharmaceuticals8/30/2019$95.25Hold???%???%ZGNXZogenix8/7/2019$49.32$71.00Buy???%???%NBIXNeurocrine Biosciences7/15/2019$88.34$113.00Buy???%???%ACADACADIA Pharmaceuticals10/4/2016$30.71$34.00Market Perform???%???%GWPHGW Pharmaceuticals10/4/2016$132.68$162.00Outperform???%???%ALKSAlkermes10/4/2016$46.94$57.00Outperform???%???%ACORAcorda Therapeutics10/4/2016$2,499.60$3,000.00Market Perform???%???%SAGESage Therapeutics10/4/2016$45.64$68.00Outperform???%???%TBPHTheravance Biopharma8/9/2016$25.44$31.00Buy???%???%SAGESage Therapeutics7/12/2016$33.65$66.00Buy???%???%GWPHGW Pharmaceuticals6/29/2016$91.93$130.00Outperform???%???%ALKSAlkermes6/28/2016$40.01$54.00Outperform???%???%GWPHGW Pharmaceuticals6/27/2016$83.31$138.00Buy???%???%GWPHGW Pharmaceuticals6/21/2016$88.42$130.00Buy???%???%SAGESage Therapeutics6/21/2016$29.59$66.00Outperform???%???%FATEFate Therapeutics6/21/2016$2.00$4.00Outperform???%???%TBPHTheravance Biopharma6/20/2016$21.82$29.00Outperform???%???%CDTXCidara Therapeutics6/12/2016$10.42Buy???%???%TBPHTheravance Biopharma6/10/2016$22.68Buy???%???%TBPHTheravance Biopharma6/4/2016$23.29Buy???%???%NBIXNeurocrine Biosciences6/1/2016$49.65$63.00Outperform???%???%ALKSAlkermes5/25/2016$43.58$58.00Outperform???%???%ACADACADIA Pharmaceuticals5/22/2016$34.04Hold???%???%ACORAcorda Therapeutics5/22/2016$3,157.20$3,480.00Hold???%???%SAGESage Therapeutics5/16/2016$32.09Buy???%???%RXDXPrometheus Biosciences5/12/2016$6.21Buy???%???%OVASOvaScience5/8/2016$6.12$7.00Hold???%???%GWPHGW Pharmaceuticals5/5/2016$78.54$130.00Outperform???%???%ACADACADIA Pharmaceuticals5/3/2016$33.00$35.00Market Perform???%???%MLNTMelinta Therapeutics5/2/2016$17.40Hold???%???%ALKSAlkermes4/21/2016$43.18Buy???%???%GWPHGW Pharmaceuticals4/19/2016$82.54$130.00Outperform???%???%SAGESage Therapeutics4/8/2016$38.51$66.00Buy???%???%ACADACADIA Pharmaceuticals3/28/2016$20.31$40.00Outperform???%???%OREXOrexigen Therapeutics3/16/2016$0.53$1.00Market Perform???%???%GWPHGW Pharmaceuticals3/14/2016$84.71$130.00Outperform???%???%FATEFate Therapeutics3/5/2016$1.97Buy???%???%FATEFate Therapeutics3/4/2016$1.97$4.00Outperform???%???%ACADACADIA Pharmaceuticals3/2/2016$19.15$40.00Buy???%???%SAGESage Therapeutics2/26/2016$30.58$66.00???%???%OREXOrexigen Therapeutics2/23/2016$1.75$2.00Market Perform???%???%GWPHGW Pharmaceuticals2/18/2016$47.79$100.00Outperform???%???%ALKSAlkermes2/16/2016$32.45$58.00Outperform???%???%NBIXNeurocrine Biosciences1/22/2016$50.37$76.00Buy???%???%ALKSAlkermes1/22/2016$36.16Buy???%???%ACORAcorda Therapeutics1/19/2016$4,788.00$4,200.00Market Perform???%???%GWPHGW Pharmaceuticals1/3/2016$69.44Buy???%???%GWPHGW Pharmaceuticals12/28/2015$69.74$129.00Buy???%???%ACADACADIA Pharmaceuticals12/15/2015$33.48$47.00Outperform???%???%GWPHGW Pharmaceuticals12/8/2015$82.24$129.00Outperform???%???%ZGNXZogenix11/27/2015$16.06$26.00Outperform???%???%ZGNXZogenix11/10/2015$11.91$26.00Outperform???%???%SAGESage Therapeutics11/7/2015$52.05Buy???%???%OREXOrexigen Therapeutics11/7/2015$2.68Buy???%???%ACADACADIA Pharmaceuticals11/7/2015$36.75Buy???%???%ACADACADIA Pharmaceuticals11/6/2015$41.54$52.00Outperform???%???%SAGESage Therapeutics11/6/2015$53.03$80.00Outperform???%???%MLNTMelinta Therapeutics10/16/2015$133.90$105.00Hold???%???%NBIXNeurocrine Biosciences10/8/2015$43.60$71.00Outperform???%???%SAGESage Therapeutics10/6/2015$41.98Outperform???%???%ZGNXZogenix10/6/2015$12.74Outperform???%???%ACORAcorda Therapeutics10/5/2015$31.42Hold???%???%ACADACADIA Pharmaceuticals9/1/2015$36.63Buy???%???%ZGNXZogenix8/11/2015$18.70Outperform???%???%SAGESage Therapeutics6/9/2015$75.15$107.00Buy???%???%SAGESage Therapeutics6/3/2015$73.81$93.00Outperform???%???%OREXOrexigen Therapeutics5/14/2015$5.02$11.00Outperform???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access